Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;197(1):79-81.
doi: 10.1007/s00066-020-01714-9.

[Proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer: a randomized phase IIB trial]

[Article in German]
Mechthild Krause  1
Affiliations
Comment

[Proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer: a randomized phase IIB trial]

[Article in German]
Mechthild Krause. Strahlenther Onkol. 2021 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lin SH, et al. Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J Clin Oncol. 2020;38(14):1569–1579. doi: 10.1200/JCO.19.02503. - DOI - PMC - PubMed
    1. Wang X, et al. Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer. J Thorac Oncol. 2020;15(10):1682–1690. doi: 10.1016/j.jtho.2020.06.014. - DOI - PMC - PubMed
    1. Wang J, et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2013;86(5):885–891. doi: 10.1016/j.ijrobp.2013.04.006. - DOI - PMC - PubMed
    1. Lin SH, et al. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiother Oncol. 2017;123(3):376–381. doi: 10.1016/j.radonc.2017.04.013. - DOI - PubMed